Cargando…
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
BACKGROUND: Prostate cancer (PCa) is one of the most malignant tumors of the male urogenital system. There is an urgent need to identify novel biomarkers for PCa. METHODS: In this study, we evaluated the expression levels of MCM10 in prostate cancer by analyzing public datasets (including The Cancer...
Autores principales: | Cui, Feilun, Hu, Jianpeng, Ning, Songyi, Tan, Jian, Tang, Huaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282949/ https://www.ncbi.nlm.nih.gov/pubmed/30095171 http://dx.doi.org/10.1002/pros.23703 |
Ejemplares similares
-
Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018) -
AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017) -
Spindle pole body component 25 regulates stemness of prostate cancer cells
por: Cui, Feilun, et al.
Publicado: (2018) -
Spindle pole body component 25 in the androgen-induced regression of castration-resistant prostate cancer
por: Cui, Feilun, et al.
Publicado: (2022) -
AB078. Knockdown of SPC25 inhibits cell proliferation and cycle progression in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)